Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Dalton Transactions (Cambridge, England : 2003)|October 10, 2023
Recent advances in the nanoarchitectonics of metal-organic frameworks for light-activated tumor therapyHuijuan Duan, Fang Wang, Weizhe Xu, et al.
Analytical Chemistry|September 11, 2023
Nano Self-Assembly for Apoptosis Induction and Early Therapeutic Efficacy MonitoringXiaoyi Meng, Yue Cheng, Fang Wang, et al.
Frontiers in Chemistry|October 24, 2022
Light-activated nanomaterials for tumor immunotherapyFang Wang, Huijuan Duan, Weizhe Xu, et al.
Hereditas|January 20, 2022
Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patientsTingming Cao, Guangming Dai, Hongqian Chu, et al.
Dalton Transactions (Cambridge, England : 2003)|August 15, 2025
Silver-loaded hollow copper sulfide particles for antibacterial therapyYue Hou, Fanling Zhang, Hong Sun, et al.
European Journal of Medical Research|April 11, 2025
Host-directed therapy for tuberculosisNa Tian, Hongqian Chu, Qi Li, et al.
Biomaterials Science|May 31, 2022
Supramolecular-mediated dual-functional DNA nanocomposites for programmable cancer therapyHongqian Chu, Xiaoyi Meng, Bingjie Liu, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|June 19, 2014
Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotypeZhaogang Sun, Yuhui Xu, Yong Sun, et al.
RSC Advances|January 30, 2023
Macrophage-targeted nanoparticles mediate synergistic photodynamic therapy and immunotherapy of tuberculosisNa Tian, Huijuan Duan, Tingming Cao, et al.
Microbes and Infection|March 27, 2024
A novel enzyme-linked ligand-sorbent assay (ELLSA) to screening pulmonary tuberculosis: a retrospective cross-sectional studyGang Sheng, Hongqian Chu, Huijuan Duan, et al.
Pageof 7